News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck Frosst Canada Ltd.'s GARDASIL(TM) Now Available In Canada



8/21/2006 8:23:39 AM

MONTREAL, Aug. 21 /CNW Telbec/ - Starting today, Merck Frosst is making GARDASIL(TM) (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) available to physicians and pharmacists across Canada. The HPV vaccine was approved last month by Health Canada for the prevention of cervical cancer, vulvar cancer, vaginal cancer, precancerous lesions and genital warts caused by the vaccine HPV types. The first doses of the vaccine were administered to two young Canadian women today.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES